Your browser doesn't support javascript.
loading
Central memory phenotype drives success of checkpoint inhibition in combination with CAR T cells.
Toews, Karin; Grunewald, Laura; Schwiebert, Silke; Klaus, Anika; Winkler, Annika; Ali, Solin; Zirngibl, Felix; Astrahantseff, Kathy; Wagner, Dimitrios L; Henssen, Anton G; Deubzer, Hedwig E; Schulte, Johannes H; Ochsenreither, Sebastian; Eggert, Angelika; Künkele, Annette.
Afiliação
  • Toews K; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt - Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Grunewald L; Berlin Institute of Health, Berlin, Germany.
  • Schwiebert S; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt - Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Klaus A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt - Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Winkler A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt - Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Ali S; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt - Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Zirngibl F; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt - Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Astrahantseff K; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt - Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Wagner DL; Berlin Institute of Health, Berlin, Germany.
  • Henssen AG; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt - Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Deubzer HE; Berlin Institute of Health, Berlin, Germany.
  • Schulte JH; BIH Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Ochsenreither S; Berlin Center for Advanced Therapies (BeCAT), Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Eggert A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt - Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Künkele A; Berlin Institute of Health, Berlin, Germany.
Mol Carcinog ; 59(7): 724-735, 2020 07.
Article em En | MEDLINE | ID: mdl-32333465
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfócitos T Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfócitos T Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha